Davenport & CO LLC Lantern Pharma Inc. Transaction History
Davenport & CO LLC
- $16 Billion
- Q2 2024
A detailed history of Davenport & CO LLC transactions in Lantern Pharma Inc. stock. As of the latest transaction made, Davenport & CO LLC holds 63,814 shares of LTRN stock, worth $238,026. This represents 0.0% of its overall portfolio holdings.
Number of Shares
63,814Holding current value
$238,026% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding LTRN
# of Institutions
41Shares Held
1.26MCall Options Held
42.8KPut Options Held
5.6K-
Vanguard Group Inc Valley Forge, PA364KShares$1.36 Million0.0% of portfolio
-
New Edge Advisors, LLC New Orleans, LA157KShares$586,0720.01% of portfolio
-
Geode Capital Management, LLC Boston, MA86.3KShares$322,0740.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny81.8KShares$305,1140.0% of portfolio
-
Cm Management, LLC80KShares$298,4000.35% of portfolio
About Lantern Pharma Inc.
- Ticker LTRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 10,830,900
- Market Cap $40.4M
- Description
- Lantern Pharma Inc., a clinical stage biotechnology company, focuses on artificial intelligence, machine learning, and genomic data to streamline the drug development process. Its advanced drug candidate is LP-100, which is in phase II clinical trials to treat metastatic, castration-resistant, and prostate cancer. The company also develops LP-30...